Document is current
Any future updates will be listed below
-
Authors
D’Addio, Francesca http://orcid.org/0000-0002-0345-0694
Maestroni, Anna
Assi, Emma
Ben Nasr, Moufida
Amabile, Giovanni
Usuelli, Vera
Loretelli, Cristian http://orcid.org/0000-0002-7583-8540
Bertuzzi, Federico
Antonioli, Barbara
Cardarelli, Francesco http://orcid.org/0000-0003-3049-5940
El Essawy, Basset
Solini, Anna http://orcid.org/0000-0002-7855-8253
Gerling, Ivan C.
Bianchi, Cristina
Becchi, Gabriella
Mazzucchelli, Serena
Corradi, Domenico http://orcid.org/0000-0002-8836-4778
Fadini, Gian Paolo
Foschi, Diego
Markmann, James F. http://orcid.org/0000-0002-2762-6535
Orsi, Emanuela
Škrha, Jan Jr http://orcid.org/0000-0001-5388-8259
Camboni, Maria Gabriella
Abdi, Reza
James Shapiro, A. M.
Folli, Franco
Ludvigsson, Johnny http://orcid.org/0000-0003-1695-5234
Del Prato, Stefano
Zuccotti, Gianvincenzo
Fiorina, Paolo http://orcid.org/0000-0002-1093-7724
-
Funding
Funding for this research was provided by:
European Foundation for the Study of Diabetes (EFSD/JDRF/Lilly Programme on Type 1 Diabetes Research 2019)
Ministero della Salute (RF-2016-02362512)
- License Information
-
More Information
Article History
Received: 27 October 2020
Accepted: 14 January 2022
First Online: 3 February 2022
Competing interests
: P.F. and F.D. hold a patent on IGFBP3/TMEM219 axis. P.F. and F.D. hold equity in Enthera S.r.l. G.A. is an employee and M.G.C. is the director of Enthera S.r.l. The remaining authors declare no competing interests.
